mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |